Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | QPCT | Q16769 | 2/20 | 0.49 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.49 |
| ▸ | PRKCI | P41743 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | MMP12 | P39900 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.41 |
| ▸ | XDH | P47989 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL11352026 | 0.98 | MAPT (0.54) | MAPTKDM4EALDH1A1APEX1RECQL | |
| Hydrochloric Acid SCHEMBL11587377 | 0.98 | MAPT (0.54) | MAPTKDM4EALDH1A1APEX1RECQL | |
| Iodide SCHEMBL11586547 | 0.98 | MAPT (0.54) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL31444162 | 0.83 | MAPT (0.48) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL3925348 | 0.83 | MAPT (0.48) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL3925343 | 0.83 | MAPT (0.48) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL12430877 | 0.83 | MAPT (0.61) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL14511179 | 0.82 | MAPT (0.68) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL12445185 | 0.79 | MAPT (0.65) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL2268960 | 0.78 | MMP12 (0.50) | MAPTKDM4EALDH1A1APEX1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119972797-A | High-strength extra-thin copper foil with dispersion strengthening copper composite structure and preparation method thereof | 山东七野电子材料有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-113166156-B | Tyrosine kinase inhibitors, compositions and methods | 贝达药业股份有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-110668988-A | Azetidines as MEK inhibitors for the treatment of proliferative diseases | 埃克塞利希斯股份有限公司 | 2020-01-10 | — | — | CN | claimed |
| CN-110461482-A | Method for isotropic structural color printing and device for detecting target substance in gas phase | UNIV NANYANG TECH | 2019-11-15 | — | — | CN | claimed |
| US-20190079014-A1 | CORE-SHELL PLASMONIC NANOGAPPED NANOSTRUCTURED MATERIAL | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2019-03-14 | — | — | US | claimed |
| CN-109311662-A | The nano structural material in nucleocapsid plasma nano gap | 南洋理工大学 | 2019-02-05 | — | — | CN | claimed |
| WO-2018117965-A1 | A PROCESS FOR ISOTROPIC STRUCTURAL COLOUR PRINTING AND AN APPARATUS FOR DETECTING A TARGET SUBSTANCE IN THE GASEOUS PHASE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2018-06-28 | — | — | WO | claimed |
| WO-2017164822-A1 | CORE-SHELL PLASMONIC NANOGAPPED NANOSTRUCTURED MATERIAL | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2017-09-28 | — | — | WO | claimed |
| WO-2016085411-A1 | METHOD FOR PREPARING A MAGNETIC CHAIN STRUCTURE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-06-02 | — | — | WO | claimed |
| EP-1002520-B1 | Composition for oxidative dying of keratinous fibres and dying process therewith | OREAL (FR) | 2008-10-29 | — | — | EP | claimed |
| WO-1999036039-A1 | KERATINOUS FIBRE OXIDATION DYEING COMPOSITION CONTAINING A LACCASE AND DYEING METHOD USING SAME | L'OREAL (FR) | 1999-07-22 | — | — | WO | claimed |
| WO-1998055083-A1 | KERATIN FIBRE OXIDATION DYEING COMPOSITION AND DYEING METHOD USING SAME | L'OREAL (FR) | 1998-12-10 | — | — | WO | claimed |
| US-5785717-A | Composition for the oxidation dyeing of keratin fibers, comprising a diaminopyrazole derivative and a heterocyclic coupler, and dyeing process | L'OREAL (FR) | 1998-07-28 | — | — | US | claimed |
| US-5769903-A | Composition for the oxidation dyeing of keratin fibers, comprising an oxidation base, an indole coupler and an additional heterocyclic coupler, and dyeing process | L'OREAL (FR) | 1998-06-23 | — | — | US | claimed |
| EP-0728464-B1 | Composition for dyeing keratinous fibers comprising a diaminopyrazole derivative and a heterocyclic coupleur and dyeing process | OREAL (FR) | 1997-07-30 | — | — | EP | claimed |
| EP-0605320-B1 | Dye composition for keratinic fibres based on paraphenylenediamine, metaphenylenediamines and benzimidazol derivates, and the dyeing process using same | OREAL (FR) | 1997-04-09 | — | — | EP | claimed |
| US-5578087-A | Dyeing compositions for keratinous fibres based on para-phenylene-diamines, meta-phenylenediamine and benzimidazole derivatives, and dyeing process employing them | L'OREAL (FR) | 1996-11-26 | — | — | US | claimed |
| EP-0728464-A1 | Composition for dyeing keratinous fibers comprising a diaminopyrazole derivative and a heterocyclic coupleur and dyeing process | L'OREAL (FR) | 1996-08-28 | — | — | EP | claimed |
| EP-0728466-A1 | Keratinous fibers oxidation dyeing composition comprising an oxidation base, an indolic coupler and an additional heterocyclic coupler and dyeing process | L'OREAL (FR) | 1996-08-28 | — | — | EP | claimed |
| EP-0605320-A1 | Dye composition for keratinic fibres based on paraphenylenediamine, metaphenylenediamines and benzimidazol derivates, and the dyeing process using same | L'OREAL (FR) | 1994-07-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190079014-A1 | CORE-SHELL PLASMONIC NANOGAPPED NANOSTRUCTURED MATERIAL | UHRF1, COMT, CD44 | MAPT 1010/4885KDM4E 1395/4885ALDH1A1 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.